Literature DB >> 18720186

Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study.

Asena Cigdem Dogramaci1, Deniz Yurtman Havlucu, Tacettin Inandi, Rajesh Balkrishnan.   

Abstract

OBJECTIVES: In this study, the objective was to evaluate the validity and reliability of the Turkish version of the melasma quality of life questionnaire (MelasQoL-Tr) for melasma patients.
METHODS: The study included 114 melasma patients. The melasma area and severity index (MASI), MelasQoL-Tr and the Turkish short version of the QoL assessment instrument from the World Health Organization (WHOQOL-BREF) were used to assess melasma severity and QoL at baseline. The reliability and validity of MelasQoL-Tr were computed.
RESULTS: The mean age of the patients in the study was 31.8 +/- 7.3 years. The internal consistency of the scale (Cronbach's alpha coefficient) was 0.88. The MelasQoL-Tr score was 29.9 +/- 14.6 (range 10-66). The total WHOQOL-BREF score was 54.8 +/- 9.8. The comparison of MelasQoL-Tr and WHOQOL-BREF questionnaires showed an inverse significant correlation on total scores, which indicated a sufficient convergent validity. According to the subscale of WHOQOL-BREF, the inverse correlation was most significant between the MelasQoL-Tr score and psychological domain and less significant between the MelasQoL-Tr score and environmental domain. The MelasQoL-Tr score and MASI were significantly correlated.
CONCLUSION: The Turkish version of the MelasQoL was valid and reliable for evaluating the quality of life of Turkish melasma patients.

Entities:  

Mesh:

Year:  2009        PMID: 18720186     DOI: 10.1080/09546630802287553

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  11 in total

1.  The effect of melasma on self-esteem: A pilot study.

Authors:  J Jiang; O Akinseye; A Tovar-Garza; A G Pandya
Journal:  Int J Womens Dermatol       Date:  2017-12-08

2.  The Effect of Melasma on the Quality of Life in a Sample of Women Living in Singapore.

Authors:  Ochi Harumi; Chee Leok Goh
Journal:  J Clin Aesthet Dermatol       Date:  2016-01

3.  Measuring melasma patients' quality of life using willingness to pay and time trade-off methods in Thai population.

Authors:  Charussri Leeyaphan; Rungsima Wanitphakdeedecha; Woraphong Manuskiatti; Kanokvalai Kulthanan
Journal:  BMC Dermatol       Date:  2011-12-19

Review 4.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

5.  Melasma and assessment of the quality of life in Brazilian women.

Authors:  Juliana Kida Ikino; Daniel Holthausen Nunes; Vanessa Priscilla Martins da Silva; Tania Silvia Fröde; Mariana Mazzochi Sens
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

6.  Quality of life in patients with melasma in Turkish women.

Authors:  Hacer Uyanikoglu; Mustafa Aksoy
Journal:  Dermatol Reports       Date:  2017-10-10

Review 7.  Evaluation Instruments for Quality of Life Related to Melasma: An Integrative Review.

Authors:  Camila Fernandes Pollo; Silmara Meneguin; Helio Amante Miot
Journal:  Clinics (Sao Paulo)       Date:  2018-05-21       Impact factor: 2.365

8.  Development and validation of a multidimensional questionnaire for evaluating quality of life in melasma (HRQ-melasma).

Authors:  Camila Fernandes Pollo; Luciane Donida Bartoli Miot; Silmara Meneguin; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

9.  Psychometrican analysis and dimensional structure of the Brazilian version of melasma quality of life scale (MELASQoL-BP).

Authors:  Camila Fernandes Pollo Maranzatto; Hélio Amante Miot; Luciane Donida Bartoli Miot; Silmara Meneguin
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

10.  Clinico-epidemiological Study and Quality of Life Assessment in Melasma.

Authors:  Ravali Yalamanchili; Veeranna Shastry; Jayadev Betkerur
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.